YANG Xu, ZHANG Xiang. Recent advances in study of mycobacterial membrane protein large 3 inhibitorsJ. Acta Pharmaceutica Sinica, 2017,52(9): 1379-1386. doi: 10.16438/j.0513-4870.2017-0058
Citation: YANG Xu, ZHANG Xiang. Recent advances in study of mycobacterial membrane protein large 3 inhibitorsJ. Acta Pharmaceutica Sinica, 2017,52(9): 1379-1386. doi: 10.16438/j.0513-4870.2017-0058

Recent advances in study of mycobacterial membrane protein large 3 inhibitors

  • Mycobacterial membrane protein large 3 (MmpL3) belongs to the resistance, nodulation and division (RND) superfamily whose role in mycobacteria is transporting trehalosemonomycolate (TMM). The inhibition of MmpL3 influences the formation of cell wall of mycobacteria. In the past few years, several whole cell-based screenings of compound libraries by different research groups has brought by a number of diverse chemical scaffolds active against Mycobacterium tuberculosis (Mtb). The aim of this review is to provide the recent advances in discovery of MmpL3 inhibitors with a special focus on the structure-activity relationship (SAR). Besides, this review will provide the information of target identification and the modes of action of the MmpL3 inhibitors.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return